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Okayama University research: Peptide directs artificial tissue growth 
  
(Okayama, 05 August) Studies on peptide-modified cultures demonstrate control over 
both tissue growth and location in vitro. 
 
“In vitro fabricated biological tissue would be a valuable tool to screen newly synthesized 
drugs or understand the tissue development process,” explain Takuya Matsumoto and his 
colleagues in a recent report. However tissues grown so far have not reached the size and 
final shape of natural tissue. Matsumoto and colleagues at Okayama, Osaka and Kansai 
Universities in Japan have now identified a tripeptide sequence that can be used to 
overcome both limitations. With hydrogel modified with the tripeptide they demonstrate 
enhanced tissue growth of a salivary gland both across a sheet of tissue and at specified 
localised points. 
 
The salivary gland studied - the submandibular gland - develops a branched structure 
through budding and the elongation of ducts, which is also typical of other structures such 
as lungs, kidneys, mammary glands and spleen. Previous research revealed the importance 
of the glycoprotein fibronectin in the morphological development and growth of salivary 
gland tissue. Consequently Matsumoto and colleagues focused their investigations on the 
effects of the specific tripeptide sequence arginine-glycine aspartic acid (RGD) that acts as a 
cell binding site on fibronectin.  
 
The researchers studied the growth of salivary gland tissue on hydrogel both modified with 
different concentrations of RGD and without and found significant growth enhancements 
that increased with RGD concentrations. They then experimented with RGD-modified 
hydrogel beads and demonstrated that localised growth enhancement occurred where the 
beads were situated, which could provide control over morphology in artificial tissue growth. 
Further studies also suggested that neuronal growth and the enhancement of growth factor 
proteins were responsible for the enhanced gland tissue growth observed. 
 
In their report of the work the researchers conclude, “This in vitro SMG tissue growth 
modulation system can have a variety of uses including tissue arrays for drug screening and 
as a biologic tool to understand tissue development.” 
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Background 
Tripeptide in previous studies 
The shape development or morphogenesis of the submandibular gland develops through 
the formation of clefts that occur through a change in cell adhesion so that they bind to the 
surrounding extracellular matrix instead of each other. Previous research has shown that 
expression of the glycoprotein fibronectin is crucial for cleft formation.  
 
Integrin is a receptor protein that bridges interactions between cells and the extracellular 
matrix. The domain of fibronectin that binds to integrin is the tripeptide sequence arginine-
glycine aspartic acid (RGD) prompting studies of this tripeptide sequence on tissue growth. 
 
Investigations have already shown that transplanting composites containing RGD peptides 
onto the back of a mouse can result in the development of growth plates – the tissue at the 
ends of bones in growing children and adolescents. However so far there have been no 
studies into the growth and morphology of tissues in vitro. The ability to grow tissues in 
vitro is particularly important for drug screening and studies to better understand tissue 
growth. 
 
The role of FGFs 
Fibroblast growth factors (FGFs) are a family of proteins involved in embryonic development, 
wound healing and signalling pathways. Two specific FGFs play a crucial role in the growth 
of the two main tissue types in the submandible salivary gland – FGF7 induces budding in 
the epithelial tissue and FGF10 induces the elongation of ducts in the mesenchymal tissue.  
 
Matsumoto and colleagues imaged the salivary gland tissues grown in RGD-modified 
hydrogels using immunofluorescent staining and found both FGF7 and FGF10 were highly 
expressed. Experiments to grow the salivary gland tissues in the presence of FGF7 and 
FGF10 antibodies revealed that these antibodies inhibited tissue growth. The RGD-modified 
hydrogel was also ineffective at enhancing tissue budding in isolated epithelial cells alone. 
 
The role of neurites 
Previous studies have also suggested that neuron outgrowths – ‘neurites’ – from a region 
known as the parasympathetic ganglion in submandibular gland tissue are key to tissue 
growth. The researchers observed an even distribution of the neurite network throughout 
the gland tissues they had grown. Antibodies to the neurotrophic factors, which are 
responsible for neuron growth and survival, also inhibited submandibular gland tissue 
growth in RGD-modified hydrogels.  
 
OKAYAMA University  
1-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530 Japan                                   © OKAYAMA University 
 
OU-MRU   Vol.13 August 2015 
 
Figure caption 
a) Schematic illustration of the RGD-modified hydrogel (left) and the submandibular gland 
(SMG) tissue culture on hydrogel (right).  b,c) SMG cultured on hydrogel sheets modified 
by introducing various RGD concentrations (0–0.18 mol/l), and SMG cultured on a tissue 
culture dish without any hydrogel substrate as a negative control (Bar = 50 μ m). A stiffer 
gel sheet normally attenuates SMG growth, but the SMG growth was enhanced when 
RGD was introduced. The SMG growth changed in accordance with the introduced 
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amount of RGD. SMG was completely dissociated when cultured on the traditional tissue 
culture dish instead of hydrogel. 
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